Breast most cancers is a posh illness with a number of elements concerned in its pathophysiological improvement. genetic mutations of BRCA1, BRCA2 and p53 are among the many most well-studied elements. The position of different genetic elements like altered expression profiles, SNPs within the regulatory areas of various genes or epigenetic elements like promoter methylation and histone modifications are additionally effectively studied however no stable understanding is offered on distinct key gamers triggering malignancy in breast most cancers, (Phosphatase and tensin homolog) PTEN is understood to be an important tumor suppressor because it has been reported to be lacking or abnormally expressed in lots of most cancers cells.
Right here on this have been studied how PTEN is expressed in malignant and benign most cancers cells by investigating its expression profile and mobile location utilizing Immuno-fluorescence microscopy. On the similar time, quantitative research of the circulatory mi-RNAs associated to the downregulation of PTEN, particularly mir-21 and mir-155 have studied additionally. Sixty biopsy samples, forty have been recognized to be malignant and twenty have been benign. It has been discovered that PTEN is generally expressed in benign samples and its usually localized within the cell membrane, whereas in malignant samples the expression degree of PTEN is decrease or absent and it’s translocated to the cytoplasm.
Apparently the quantitative expression of circulatory mir-21 and mir-155 within the blood plasma of the corresponding sufferers confirmed a associated sample with greater expression in malignant samples, subsequently can it is clear that PTEN is within the cross-talk of genetics and epigenetic regulation in regard of the event of malignant breast most cancers. On the similar time, this examine confirms the significance of circulatory miRNAs as a biomarker for early breast most cancers detection.
Transcriptome-wide profiles of round RNA and RNA-binding protein interactions reveal results on round RNA biogenesis and most cancers pathway expression
Background: Round RNAs (circRNAs) are steady, usually extremely expressed RNA transcripts with potential to modulate different regulatory RNAs. Just a few circRNAs have been proven to bind RNA-binding proteins (RBPs); nonetheless, little is understood in regards to the prevalence and distribution of those interactions in several organic contexts.
Strategies: We conduct an in depth display of circRNA-RBP interactions within the ENCODE cell strains HepG2 and Okay562. We profile circRNAs in deep-sequenced whole RNA samples and analyze circRNA-RBP interactions utilizing a big set of eCLIP information with binding websites of 150 RBPs. We validate interactions for choose circRNAs and RBPs by performing RNA immunoprecipitation and functionally characterize our most attention-grabbing candidates by conducting knockdown research adopted by RNA-Seq.
Outcomes: We generate a complete catalog of circRNA-RBP interactions in HepG2 and Okay562 cells. We present that KHSRP binding websites are enriched in flanking introns of circRNAs and that KHSRP depletion impacts circRNA biogenesis. We determine circRNAs which might be extremely lined by RBP binding websites and experimentally validate particular person circRNA-RBP interactions. We present that circCDYL, a extremely expressed circRNA with scientific and useful implications in bladder most cancers, is sort of fully lined with GRWD1 binding websites in HepG2 cells, and that circCDYL depletion counteracts the impact of GRWD1 depletion. Moreover, we verify interactions between circCDYL and RBPs in bladder most cancers cells and exhibit that circCDYL depletion impacts hallmarks of most cancers and perturbs the expression of key most cancers genes, e.g., TP53. Lastly, we present that elevated ranges of circCDYL are related to total survival of bladder most cancers sufferers.
Conclusions: Our examine demonstrates transcriptome-wide and cell-type-specific circRNA-RBP interactions that would play necessary regulatory roles in tumorigenesis.

Circulatory miRNA-155, miRNA-21 target PTEN expression and activity as a factor in breast cancer development
Sudden tumor response to palliative pelvic radiotherapy in mismatch repair-deficient superior prostate most cancers: a case report
Background: Mismatch-repair-deficiency leading to microsatellite instability (MSI) could confer elevated radiosensitivity in regionally superior/metastatic tumors and thus radiotherapy (RT) probably may need a altering position in treating this subset of sufferers, alone or together with checkpoint inhibitors.
Case presentation: We report a 76 year-old Italian male affected person presenting with regionally superior undifferentiated prostate most cancers (LAPC), infiltrating bladder and rectum. Molecular evaluation revealed high-MSI with an altered expression of MSH2 and MSH6 at immunohistochemistry. Two months after 6 chemotherapy cycles with Docetaxel related to an LHRH analogue, a computed tomography scan confirmed steady illness. After palliative RT (30 Gy/10 fractions) directed to the tumor mass with a 3D-conformal setup, a follow-up computed tomography scan at eight weeks revealed a formidable response that remained steady at computed tomography after 9 months, with sustained biochemical response. To our information, that is the primary case of such a sustained response to low dose RT alone in high-MSI LAPC.
Breast cancer |
BR725 |
TissueArray |
each |
EUR 270 |
Description: Breast cancer, adjacent and adjacent normal tissue array, 68 cases/72 cores |
Breast cancer with cancer adjacent breast tissue array |
BC081116e |
TissueArray |
each |
EUR 306 |
Description: Breast cancer with cancer adjacent breast tissue array, including invasive carcinoma of no special type, breast carcinoma with apocrine differentiation and AT tissue,pat hology grade, IHC (ER/PR/Her-2/Ki67) info, TNM/Stage (AJCC 7th edition), 107 cases/110 cores (core size 1.5mm), replacing BC081116d |
Breast cancer TMA |
BR602 |
TissueArray |
each |
EUR 270 |
Description: Breast cancer TMA, 3 samples have matched cancer adjacent tissue samples, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 57 cases/60 cores (Core Size 1.5mm), recent tear collections |
Breast cancer-overexpressed gene 1 protein |
E8M1210-6 |
EnoGene |
100ul |
EUR 275 |
Description: Available in various conjugation types. |
Breast Cancer Metastasis Suppressor 1 Protein |
20-abx263402 |
Abbexa |
-
EUR 1930.80
-
EUR 393.60
-
EUR 276.00
|
|
|
Breast Cancer Exosome |
P141-BR |
101Bio |
- |
Ask for price |
Breast cancer with matched cancer adjacent breast tissue array |
BR804b |
TissueArray |
each |
EUR 306 |
Description: Breast cancer with matched cancer adjacent breast tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki67), 40 cases/80 cores, replacing BR804a |
Breast Cancer Cell Protein 2 (BRCC2) Antibody |
20-abx141388 |
Abbexa |
-
EUR 444.00
-
EUR 727.20
-
EUR 360.00
|
|
|
Amplified In Breast Cancer 1 Protein (NCOA3) Antibody |
abx011671-100ul |
Abbexa |
100 ul |
EUR 493.2 |
|
Breast cancer with breast tissue array |
BC08118a |
TissueArray |
each |
EUR 258 |
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 100 cases/100 cores (core size 1.0mm), replacing BC08118 |
Breast cancer with breast tissue array |
BR2085d |
TissueArray |
each |
EUR 546 |
Description: Breast cancer with breast tissue array, including pathology grad, TNM and clinical stage, 188 cases/208 cores, replacing BR2085c |
Breast cancer with breast tissue array |
BR246d |
TissueArray |
each |
EUR 66 |
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage (reference AJCC 7th version), 12 cases/24 cores, replacing BR246c |
Breast cancer with breast tissue array |
BR482 |
TissueArray |
each |
EUR 198 |
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores |
Breast cancer with breast tissue array |
BR720 |
TissueArray |
each |
EUR 270 |
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical satge (reference AJCC 7th version), 72 cases/72 cores |
Breast cancer with breast tissue array |
T087d |
TissueArray |
each |
EUR 66 |
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T087c |
Breast cancer with breast tissue array |
T088d |
TissueArray |
each |
EUR 66 |
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T088c |
SNCG (breast cancer-specific protein 1) Antibody |
BF0110 |
Affbiotech |
200ul |
EUR 540 |
SNCG Antibody (breast cancer-specific protein 1) |
E10-20084 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
Breast Cancer Anti-Estrogen Resistance 1 Protein |
20-abx262743 |
Abbexa |
-
EUR 393.60
-
EUR 7676.40
-
EUR 276.00
|
|
|
Rat Breast Cancer Susceptibility Protein 1 (BRCA1) Protein |
20-abx065606 |
Abbexa |
-
EUR 944.40
-
EUR 360.00
-
EUR 3015.60
-
EUR 1144.80
-
EUR 678.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Breast Cancer Susceptibility Protein 2 (BRCA2) Protein |
20-abx166163 |
Abbexa |
-
EUR 910.80
-
EUR 360.00
-
EUR 2848.80
-
EUR 1078.80
-
EUR 644.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
SNCG (breast cancer-specific protein 1) Mouse mAb |
E2220104 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Breast Cancer Exosome RNA |
P241-BR |
101Bio |
- |
Ask for price |
Human Breast Cancer Susceptibility Protein 2 (BRCA2) Protein |
20-abx065607 |
Abbexa |
-
EUR 878.40
-
EUR 343.20
-
EUR 2766.00
-
EUR 1062.00
-
EUR 627.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Breast Cancer Susceptibility Protein 1 (BRCA1) Protein |
20-abx065605 |
Abbexa |
-
EUR 994.80
-
EUR 376.80
-
EUR 3199.20
-
EUR 1195.20
-
EUR 693.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Breast Cancer Susceptibility Protein 1 (BRCA1) Protein |
20-abx166161 |
Abbexa |
-
EUR 878.40
-
EUR 343.20
-
EUR 2715.60
-
EUR 1045.20
-
EUR 627.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Breast Cancer Susceptibility Protein 2 (BRCA2) Protein |
20-abx166162 |
Abbexa |
-
EUR 878.40
-
EUR 343.20
-
EUR 2766.00
-
EUR 1062.00
-
EUR 627.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody |
20-abx104049 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1378.80
-
EUR 678.00
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody |
20-abx104050 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1496.40
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody |
20-abx104051 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1378.80
-
EUR 678.00
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody |
20-abx175628 |
Abbexa |
|
|
|
Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody |
20-abx171476 |
Abbexa |
|
|
|
Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody |
20-abx171477 |
Abbexa |
|
|
|
Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody |
20-abx129675 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1412.40
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody |
20-abx129746 |
Abbexa |
-
EUR 360.00
-
EUR 159.60
-
EUR 961.20
-
EUR 510.00
-
EUR 309.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody |
20-abx130340 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1479.60
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Breast cancer-overexpressed gene 1 protein Antibody |
48092-100ul |
SAB |
100ul |
EUR 399.6 |
Breast cancer-overexpressed gene 1 protein Antibody |
48092-50ul |
SAB |
50ul |
EUR 286.8 |
Anti-Human Breast Cancer Resistance Protein antibody |
STJ16100907 |
St John's Laboratory |
1 mL |
EUR 573.6 |
Anti-Mouse Breast Cancer Resistance Protein antibody |
STJ16100917 |
St John's Laboratory |
1 mL |
EUR 573.6 |
Breast cancer tissue array with cancer adjacent breast tissue as control |
BR208a |
TissueArray |
each |
EUR 474 |
Description: Breast cancer tissue array with cancer adjacent breast tissue as control, including TNM, clinical stage and pathology grade, 69 cases/ 207 cores. |
Breast cancer tissue array |
BR042b |
TissueArray |
each |
EUR 78 |
Description: Breast cancer tissue array, including TNM and pathology grade, 4 cases/4 cores, replacing BR042a |
Breast cancer tissue array |
BR1006a |
TissueArray |
each |
EUR 306 |
Description: Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores (core size 1.0mm), replacing BR1006 |
Breast cancer tissue array |
BR1141a |
TissueArray |
each |
EUR 354 |
Description: Breast cancer tissue array, including pathology grade, TNM and clinical stage, IHC marker (ER, PR, HER2 and Ki-67), 114 cases/114 cores, replacing BR1141 |
Breast cancer tissue array |
BR1401 |
TissueArray |
each |
EUR 414 |
Description: Breast cancer tissue array, including TNM and pathology grade, IHC markers ER/PR/Her-2 results, 140 cases/140 cores (core size 1.0mm) |
Breast cancer tissue array |
BR1503f |
TissueArray |
each |
EUR 306 |
Description: Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her-2\ER\PR\Ki67, 75 cases/ 150 cores, replacing BR1503e |
Breast cancer tissue array |
BR1505e |
TissueArray |
each |
EUR 306 |
Description: Breast cancer tissue array, including pathology grade, TNM, clinical stage, and IHC(HER2/ER/PR/Ki67), 75 cases/150 cores, replacing BR1505d |
Breast cancer tissue array |
BR2161 |
TissueArray |
each |
EUR 546 |
Description: Breast cancer tissue array, including TNM and pathology grade, 216 cases/216 cores |
Breast cancer tissue array |
BR247a |
TissueArray |
each |
EUR 234 |
Description: Breast cancer tissue array, with normal tissue, including TNM and pathology grade, IHC marker (HER2), 24 cases/48 cores replacing BR247 |
Breast cancer tissue array |
BR488 |
TissueArray |
each |
EUR 306 |
Description: Breast cancer tissue array, including pathology grade, TNM, clinical stage (AJCC 7th edition), and IHC marker(ER,PR,Her-2), 48 cases/48 cores |
Breast cancer tissue array |
BR501 |
TissueArray |
each |
EUR 270 |
Description: Breast cancer tissue array, including TNM and pathology grade, 50 cases/ 50 cores (core size 1.5mm) |
Breast cancer tissue array |
BR8015a |
TissueArray |
each |
EUR 306 |
Description: Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases/80 cores, replacing BC08014 |
Breast cancer tissue array |
BR964 |
TissueArray |
each |
EUR 222 |
Description: Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores |
Breast cancer tissue array |
T089c |
TissueArray |
each |
EUR 48 |
Description: Breast cancer tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores(1.5mm), replacing T089b |
Breast cancer (including one case of male breast cancer) with adjacent normal breast tissue array |
BC081120g |
TissueArray |
each |
EUR 306 |
Description: Breast cancer (including one case of male breast cancer) with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage (AJCC 7th edition) with IHC results ER/PR/Her2/Ki67,110 cases/110 cores (core size 1.0 mm), replacing BC081120f |
Rat Breast Cancer Susceptibility Protein 1 ELISA kit |
E02B0459-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Breast Cancer Susceptibility Protein 1 ELISA kit |
E02B0459-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Breast Cancer Susceptibility Protein 1 ELISA kit |
E02B0459-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Breast Cancer Susceptibility Protein 2 ELISA kit |
E02B0460-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Rat Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Breast Cancer Susceptibility Protein 2 ELISA kit |
E02B0460-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Rat Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Breast Cancer Susceptibility Protein 2 ELISA kit |
E02B0460-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Rat Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Breast Cancer Susceptibility Protein 1 ELISA kit |
E08B0459-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Breast Cancer Susceptibility Protein 1 ELISA kit |
E08B0459-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Canine Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Breast Cancer Susceptibility Protein 2 ELISA kit |
E08B0460-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Canine Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Breast Cancer Susceptibility Protein 2 ELISA kit |
E08B0460-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Canine Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Breast Cancer Susceptibility Protein 2 ELISA kit |
E08B0460-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Canine Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Breast Cancer Susceptibility Protein 1 ELISA kit |
E07B0459-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Breast Cancer Susceptibility Protein 1 ELISA kit |
E07B0459-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Breast Cancer Susceptibility Protein 1 ELISA kit |
E07B0459-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Breast Cancer Susceptibility Protein 2 ELISA kit |
E07B0460-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Breast Cancer Susceptibility Protein 2 ELISA kit |
E07B0460-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Breast Cancer Susceptibility Protein 2 ELISA kit |
E07B0460-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Breast Cancer Susceptibility Protein 1 ELISA kit |
E08B0459-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) |
4-RPB376Hu01 |
Cloud-Clone |
-
EUR 722.11
-
EUR 316.80
-
EUR 2377.92
-
EUR 872.64
-
EUR 1625.28
-
EUR 559.20
-
EUR 5764.80
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Breast Cancer Susceptibility Protein 1 expressed in: E.coli |
Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) |
4-RPB376Mu01 |
Cloud-Clone |
-
EUR 625.34
-
EUR 290.40
-
EUR 2015.04
-
EUR 751.68
-
EUR 1383.36
-
EUR 494.40
-
EUR 4857.60
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Mouse Breast Cancer Susceptibility Protein 1 expressed in: E.coli |
Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) |
4-RPB376Ra01 |
Cloud-Clone |
-
EUR 685.56
-
EUR 307.20
-
EUR 2240.83
-
EUR 826.94
-
EUR 1533.89
-
EUR 534.00
-
EUR 5422.08
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Rat Breast Cancer Susceptibility Protein 1 expressed in: E.coli |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
4-RPB364Hu01 |
Cloud-Clone |
-
EUR 636.10
-
EUR 294.00
-
EUR 2055.36
-
EUR 765.12
-
EUR 1410.24
-
EUR 501.60
-
EUR 4958.40
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Breast Cancer Susceptibility Protein 2 expressed in: E.coli |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
4-RPB364Mu01 |
Cloud-Clone |
-
EUR 636.10
-
EUR 294.00
-
EUR 2055.36
-
EUR 765.12
-
EUR 1410.24
-
EUR 501.60
-
EUR 4958.40
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Mouse Breast Cancer Susceptibility Protein 2 expressed in: E.coli |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
4-RPB364Ra01 |
Cloud-Clone |
-
EUR 653.30
-
EUR 297.60
-
EUR 2119.87
-
EUR 786.62
-
EUR 1453.25
-
EUR 512.40
-
EUR 5119.68
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Rat Breast Cancer Susceptibility Protein 2 expressed in: E.coli |
Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) |
RPU40524-100ug |
Biomatik Corporation |
100ug |
EUR 689.7 |
Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) |
RPU40524-1mg |
Biomatik Corporation |
1mg |
EUR 3057.6 |
Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) |
RPU40524-50ug |
Biomatik Corporation |
50ug |
EUR 554.4 |
Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) |
RPU40525-100ug |
Biomatik Corporation |
100ug |
EUR 647.9 |
Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) |
RPU40525-1mg |
Biomatik Corporation |
1mg |
EUR 2871.7 |
Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) |
RPU40525-50ug |
Biomatik Corporation |
50ug |
EUR 520.3 |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
RPU40526-100ug |
Biomatik Corporation |
100ug |
EUR 591.8 |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
RPU40526-1mg |
Biomatik Corporation |
1mg |
EUR 2620.8 |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
RPU40526-50ug |
Biomatik Corporation |
50ug |
EUR 475.2 |
Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) |
RPU54182-100ug |
Biomatik Corporation |
100ug |
EUR 578.6 |
Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) |
RPU54182-1mg |
Biomatik Corporation |
1mg |
EUR 2566.2 |
Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) |
RPU54182-50ug |
Biomatik Corporation |
50ug |
EUR 465.3 |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
RPU54352-100ug |
Biomatik Corporation |
100ug |
EUR 591.8 |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
RPU54352-1mg |
Biomatik Corporation |
1mg |
EUR 2620.8 |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
RPU54352-50ug |
Biomatik Corporation |
50ug |
EUR 475.2 |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
RPU54557-100ug |
Biomatik Corporation |
100ug |
EUR 611.6 |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
RPU54557-1mg |
Biomatik Corporation |
1mg |
EUR 2707.9 |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
RPU54557-50ug |
Biomatik Corporation |
50ug |
EUR 490.6 |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
RPU56953-100ug |
Biomatik Corporation |
100ug |
EUR 470.4 |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
RPU56953-1mg |
Biomatik Corporation |
1mg |
EUR 2184 |
Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) |
RPU56953-50ug |
Biomatik Corporation |
50ug |
EUR 385 |
Breast Cancer-Specific Gene 1 Protein (SNCG) Antibody |
abx011543-100ul |
Abbexa |
100 ul |
EUR 493.2 |
|
anti-SNCG (breast cancer-specific protein 1) (1H10D2) |
LF-MA30069 |
Abfrontier |
100 ul |
EUR 534 |
Description: Mouse Monoclonal to SNCG (breast cancer-specific protein 1) |
Goat Breast Cancer Susceptibility Protein 1 ELISA kit |
E06B0459-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Goat Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Breast Cancer Susceptibility Protein 1 ELISA kit |
E06B0459-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Goat Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Breast Cancer Susceptibility Protein 1 ELISA kit |
E06B0459-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Goat Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Breast Cancer Susceptibility Protein 2 ELISA kit |
E06B0460-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Goat Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Breast Cancer Susceptibility Protein 2 ELISA kit |
E06B0460-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Goat Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Breast Cancer Susceptibility Protein 2 ELISA kit |
E06B0460-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Goat Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Breast cancer with matched breast tissue array |
BR251e |
TissueArray |
each |
EUR 60 |
Description: Breast cancer with matched breast tissue array, including pathology grade, IHC info (ER,PR,Her-2,Ki67),TNM\Stage, 6 cases/24 cores (core size 1.5mm), replacing BR251d |
Human Breast Cancer Susceptibility Protein 1 ELISA kit |
E01B0459-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Breast Cancer Susceptibility Protein 1 ELISA kit |
E01B0459-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Breast Cancer Susceptibility Protein 1 ELISA kit |
E01B0459-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Breast Cancer Susceptibility Protein 2 ELISA kit |
E01B0460-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Human Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Breast Cancer Susceptibility Protein 2 ELISA kit |
E01B0460-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Human Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Breast Cancer Susceptibility Protein 2 ELISA kit |
E01B0460-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Human Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Breast Cancer Susceptibility Protein 1 ELISA kit |
E03B0459-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Breast Cancer Susceptibility Protein 1 ELISA kit |
E03B0459-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Breast Cancer Susceptibility Protein 1 ELISA kit |
E03B0459-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Breast Cancer Susceptibility Protein 2 ELISA kit |
E03B0460-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Breast Cancer Susceptibility Protein 2 ELISA kit |
E03B0460-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Breast Cancer Susceptibility Protein 2 ELISA kit |
E03B0460-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Breast Cancer Susceptibility Protein 2 ELISA Kit |
IMSBRCA2KT |
Innovative research |
each |
EUR 718 |
|
Description: Mouse Breast Cancer Susceptibility Protein 2 ELISA Kit |
Human Breast Cancer Susceptibility Protein 1 ELISA Kit |
IHUBRCA1KT |
Innovative research |
each |
EUR 700 |
|
Description: Human Breast Cancer Susceptibility Protein 1 ELISA Kit |
Human Breast Cancer Susceptibility Protein 2 ELISA Kit |
IHUBRCA2KT |
Innovative research |
each |
EUR 700 |
|
Description: Human Breast Cancer Susceptibility Protein 2 ELISA Kit |
Multiple breast cancer with breast tissue array |
BR087e |
TissueArray |
each |
EUR 48 |
Description: Multiple breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR087d |
Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody |
20-abx133658 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody |
abx025588-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody |
abx025588-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody |
20-abx013807 |
Abbexa |
-
EUR 376.80
-
EUR 117.60
-
EUR 477.60
-
EUR 594.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
Human Breast cancer type 1 susceptibility protein (BRCA1) |
1-CSB-RP096594h(N) |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Breast cancer type 1 susceptibility protein(BRCA1),partial expressed in E.coli |
Rabbit Breast Cancer Susceptibility Protein 1 ELISA kit |
E04B0459-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Breast Cancer Susceptibility Protein 1 ELISA kit |
E04B0459-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Breast Cancer Susceptibility Protein 1 ELISA kit |
E04B0459-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Breast Cancer Susceptibility Protein 2 ELISA kit |
E04B0460-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Breast Cancer Susceptibility Protein 2 ELISA kit |
E04B0460-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Breast Cancer Susceptibility Protein 2 ELISA kit |
E04B0460-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Breast Cancer Susceptibility Protein 1 ELISA kit |
E09B0459-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Breast Cancer Susceptibility Protein 1 ELISA kit |
E09B0459-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Breast Cancer Susceptibility Protein 1 ELISA kit |
E09B0459-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Breast Cancer Susceptibility Protein 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Breast Cancer Susceptibility Protein 2 ELISA kit |
E09B0460-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Breast Cancer Susceptibility Protein 2 ELISA kit |
E09B0460-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Breast Cancer Susceptibility Protein 2 ELISA kit |
E09B0460-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey Breast Cancer Susceptibility Protein 2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
SNCG (breast cancer-specific protein 1) Blocking Peptide |
BF0110-BP |
Affbiotech |
1mg |
EUR 234 |
Breast disease spectrum (breast cancer progression) tissue array |
BR2082c |
TissueArray |
each |
EUR 546 |
Description: Breast disease spectrum (breast cancer progression) tissue array, including pathology grade, TNM and clinical stage, IHC marker (ER, PR, HER2 and Ki-67), 186 cases/192 cores, replacing BR2082b |
Conclusions: Routine analysis of MSI in sufferers with regionally problematic superior tumors would possibly change therapy technique and therapy purpose on this setting, from a purely palliative strategy to a quasi-curative paradigm.